News & Updates

Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
15 Nov 2021 byElvira Manzano

Higher intake of alcohol and reduced care during the COVID-19 pandemic have triggered a spike in alcohol-related liver diseases, leading to some serious consequences, according to new research.

Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
15 Nov 2021
Dietary acrylamide compromises physical performance in knee OA
Dietary acrylamide compromises physical performance in knee OA
14 Nov 2021

In people with knee osteoarthritis (OA) or are at high risk of such condition, dietary acrylamide seems to worsen physical performance and may potentially increase the risk of sarcopoenia, a recent study has found.

Dietary acrylamide compromises physical performance in knee OA
14 Nov 2021
Selenium may increase type 2 diabetes risk
Selenium may increase type 2 diabetes risk
14 Nov 2021

Selenium appears to reduce lipids and heighten the risk of type 2 diabetes (T2D), potentially via insulin resistance instead of pancreatic beta cell function, suggests a study.

Selenium may increase type 2 diabetes risk
14 Nov 2021
Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
14 Nov 2021

Statin reduces the risk of cardiovascular disease and mortality in type 2 diabetes, and this beneficial effect is evident among middle-aged and, to a lesser extent, older patients but not among young patients, a study has found.

Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
14 Nov 2021
Medicine uptitration amps up RDN benefit for drug-resistant hypertension
Medicine uptitration amps up RDN benefit for drug-resistant hypertension
14 Nov 2021 byAudrey Abella

In patients with multidrug-resistant hypertension (HTN), the blood pressure (BP)-lowering benefit of renal denervation (RDN) achieved at 2 months was amplified when a stepped-care medication escalation protocol was added between 2 and 6 months, updates from the RADIANCE-HTN TRIO trial have shown.

Medicine uptitration amps up RDN benefit for drug-resistant hypertension
14 Nov 2021